Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-04-24 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares, dates, quantities, prices, and confirmations that these repurchases comply with listing rules of the Stock Exchange of Hong Kong. The document is a regulatory disclosure about share repurchases and capital changes, not a financial report or earnings release. It is not an announcement of a report publication but a detailed disclosure itself. This fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2024-04-24 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates, quantities, and prices, as well as confirmations related to the authorization and compliance of these transactions. The document references rules from the Stock Exchange of Hong Kong (SEHK) and is a regulatory disclosure of share repurchase activity. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is lengthy (15,000 characters) and contains substantive data on share repurchases, not merely an announcement or certification. Therefore, the appropriate classification is 'POS' (Transaction in Own Shares).
2024-04-23 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes extensive data on repurchases of shares, dates, quantities, prices, and confirmations related to compliance with listing rules on the Stock Exchange of Hong Kong. The content focuses on share repurchase activities and disclosures required by the exchange rules. There is no indication of financial statements, earnings data, management discussion, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. The document is substantive and detailed, not a mere announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2024-04-22 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length and content confirm it is the actual report of share repurchases, not merely an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-04-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over a period, including dates, quantities, and prices. The document references compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. It includes confirmations by company officers regarding authorization and compliance with listing rules. The content is focused on reporting share repurchase transactions and changes in issued share capital, which aligns with announcements of share buybacks or capital changes rather than a full financial report or earnings release. The document is lengthy (over 14,000 characters) and contains detailed transactional data, not just a brief announcement or certification. Therefore, the appropriate classification is a report on transactions in own shares (share repurchases).
2024-04-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and changes in issued shares, which aligns with the category of 'Transaction in Own Shares' (POS). The document is lengthy and contains detailed transactional data, not merely an announcement or a brief summary, so it is not a report publication announcement or regulatory filing. Therefore, the appropriate classification is POS.
2024-04-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.